Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

Clinical Trials at the Summit

Clinical Trials at the Summit brings together a diverse group of experts from around the world to discuss ongoing clinical trials and latest data, with the goal to achieving advances in vitreoretinal care.

Oxurion CEO, Tom Graney, and CDO, Andy De Deene, M.D., will be joining a panel discussion.

Please follow this link for more information and registration.

Date: 
Saturday, August 28, 2021
Type: 
Conferences & Events